Details for Patent: 9,481,639
✉ Email this page to a colleague
Which drugs does patent 9,481,639 protect, and when does it expire?
Patent 9,481,639 protects SEYSARA and is included in one NDA.
This patent has fourteen patent family members in twelve countries.
Summary for Patent: 9,481,639
| Title: | Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| Abstract: | Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described. |
| Inventor(s): | Assefa; Haregewein (Braintree, MA), Bhatia; Beena (Mansfield, MA), Draper; Michael P. (Windham, NH), Honeyman; Laura (Etobicoke, CA), Kim; Oak K. (Cambridge, MA), Molnar; Dennis P. (Hopkinton, MA) |
| Assignee: | Paratek Pharmaceuticals, Inc. (Boston, MA) |
| Application Number: | 13/987,655 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,481,639
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-001 | Oct 1, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD FOR TREATING ACNE IN INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS PATIENTS 9 YEARS OF AGE AND OLDER COMPRISING ADMINISTERING SARECYCLINE HYDROCHLORIDE IN 60 MG, 100 MG OR 150 MG EQUIVALENT DOSES | ⤷ Try a Trial | ||||
| Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-002 | Oct 1, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD FOR TREATING ACNE IN INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS PATIENTS 9 YEARS OF AGE AND OLDER COMPRISING ADMINISTERING SARECYCLINE HYDROCHLORIDE IN 60 MG, 100 MG OR 150 MG EQUIVALENT DOSES | ⤷ Try a Trial | ||||
| Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-003 | Oct 1, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD FOR TREATING ACNE IN INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS PATIENTS 9 YEARS OF AGE AND OLDER COMPRISING ADMINISTERING SARECYCLINE HYDROCHLORIDE IN 60 MG, 100 MG OR 150 MG EQUIVALENT DOSES | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,481,639
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2007338681 | ⤷ Try a Trial | |||
| Canada | 2673486 | ⤷ Try a Trial | |||
| Canada | 2892739 | ⤷ Try a Trial | |||
| Cyprus | 1121135 | ⤷ Try a Trial | |||
| Denmark | 2120963 | ⤷ Try a Trial | |||
| European Patent Office | 2120963 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
